tweenvest

J-Pharma Co., Ltd. (TSE: 520A)

Health Care · Biotechnology · JP

¥336.00

+0.30% today · -52.0% 1Y

Public summary
A free snapshot of J-Pharma Co., Ltd., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

J-Pharma Co., Ltd. (TSE: 520A) operates in the Biotechnology industry within the Health Care sector. The company is valued at $38.10M and employs 16 people.

Over the last twelve months the share price has lost 52.0%, trading between 260.00 and 809.00.

Tweenvest scores J-Pharma Co., Ltd. across four factors: quality 44/100, value 100/100. Its strongest factor is value.

520A price history

Mar 27, 2026 · 738.00Weekly closes 269.00 – 738.00Nov 18, 2026 · 336.00

Key figures

Market cap
$38.10M
Revenue (TTM)
—
P/E
-2.33
EPS
-195.08
Dividend yield
—
Beta (5Y)
—
52-week high
¥809.00
52-week low
¥260.00
Avg volume (3M)
—
Shares outstanding
18.06M
Employees
16
Next earnings
—

About J-Pharma Co., Ltd.

J-Pharma Co., Ltd. is engaged in drug discovery and development, focusing on amino acid transporters as drug targets. The company researches and develops drugs targeting solute carrier (SLC) transporters, with emphasis on the LAT1 amino acid transporter. It is developing several compounds for various medical indications, including JPH034 for central nervous system demyelinating diseases and multiple sclerosis. The company conducts functional and structural analysis of selected SLC transporters to support drug discovery, collaborates with academic institutions, and participates in joint research for new pharmaceutical development. It is preparing for clinical trials and global distribution of its drug candidates. The company was founded in 2005 and is based in Yokohama, Japan.

ISIN
JP3387030004
Founded
2005
Listed since
Mar 25, 2026
Exchange
The Tokyo Stock Exchange
Currency
JPY
CompanyMarket capPriceDay
Psomagen, Inc.KOSDAQ: A950200$38.71M₩2,690.00+0.37%
Biomea Fusion, Inc.NasdaqGS: BMEA$38.52M$0.53+8.61%
GENINUS Inc.KOSDAQ: A389030$38.50M₩1,305.00+2.11%
TMS Co., Ltd.TSE: 4891$38.42M¥134.00-2.90%
OSE Immunotherapeutics SAENXTPA: OSE$37.63M€1.46-10.60%
Isofol Medical AB (publ)OM: ISOFOL$37.23MSkr1.16-15.90%
NeoCore Technology Co., Ltd.TPEX: 4131$37.01MNT$30.55-1.29%
Elutia Inc.NasdaqCM: ELUT$36.32M$0.82-6.69%

Browse every Biotechnology company →